Obtenez les faits, trouvez le meilleur et évitez la fraude
Legal Name: BAKER BROS. ADVISORS LP
Période de rapport:
Jun 30, 2019
Date d\'entrée en vigueur:
Aug 14, 2019
| Sécurité |
Actions détenues / capital |
Valeur marchande |
Option |
|
SEATTLE GENETICS INC (812578102)
|
50,057,277 |
$3,464,464k |
|
|
Incyte Corp (45337C102)
|
31,976,193 |
$2,716,697k |
|
|
BEIGENE LTD-ADR (07725L102)
|
11,777,285 |
$1,459,794k |
|
|
ALEXION PHARMACEUTICALS INC CO (015351109)
|
8,258,068 |
$1,081,642k |
|
|
ACADIA PHARMACEUTCLS (004225108)
|
39,292,086 |
$1,050,277k |
|
|
B. Riley Wealth Management, Inc. (023111206)
|
41,544,288 |
$805,544k |
|
|
BIOMARIN PHARMACEUTICAL INC (09061G101)
|
7,589,294 |
$650,023k |
|
|
GENOMIC HEALTH (37244C101)
|
9,260,922 |
$538,708k |
|
|
ASCENDIS PHARMA A S (04351P101)
|
3,390,270 |
$390,390k |
|
|
MIRATI THERAPEUTICS INC (60468T105)
|
2,513,462 |
$258,887k |
|
|
Argenx SE Sponsored ADR (04016X101)
|
1,019,557 |
$144,349k |
|
|
Array Biopharma Inc (04269X105)
|
2,848,567 |
$131,974k |
|
|
MADRIGAL PHARMACEUTICALS INC (558868105)
|
1,169,278 |
$122,552k |
|
|
Neurocrine Biosciences Inc. (64125C109)
|
1,415,283 |
$119,492k |
|
|
HERON THERAPEUTICS INC (427746102)
|
6,018,104 |
$111,877k |
|
|
KODIAK SCIENCES INC (50015M109)
|
9,145,115 |
$106,998k |
|
|
Invitae Corp (46185L103)
|
3,902,421 |
$91,707k |
|
|
TRICIDA INC (89610F101)
|
1,969,905 |
$77,732k |
|
|
SPARK THERAPEUTICS INC (84652J103)
|
751,927 |
$76,982k |
|
|
Atreca, Inc. (04965G109)
|
3,532,760 |
$66,557k |
|
|
GW PHARMACEUTICALS PLC ADS (36197T103)
|
370,845 |
$63,930k |
|
|
INSMED INC (457669307)
|
2,462,216 |
$63,033k |
|
|
Cerus Corp (157085101)
|
10,749,937 |
$60,415k |
|
|
Rhythm Pharmaceuticals, Inc. (76243J105)
|
2,708,200 |
$59,580k |
|
|
PRINCIPIA BIOPHARMA INC (74257L108)
|
1,787,807 |
$59,337k |
|
|
AUDENTES THERAPEUTICS INC COM (05070R104)
|
1,506,438 |
$57,034k |
|
|
ADAPTIVE BIOTECHNOLOGIES COR (00650F109)
|
1,165,411 |
$56,289k |
|
|
BIOCRYST PHARMACEUTICALS (09058v103)
|
14,382,673 |
$54,510k |
|
|
RA PHARMACEUTICALS (74933V108)
|
1,801,695 |
$54,177k |
|
|
MYOKARDIA INC (62857M105)
|
1,016,306 |
$50,958k |
|
|
DBV TECHNOLOGIES SA-SPON ADR (23306J101)
|
5,509,560 |
$45,289k |
|
|
KRYSTAL BIOTECH INC (501147102)
|
1,034,674 |
$41,666k |
|
|
CymaBay Therapeutics, Inc. (23257D103)
|
5,707,411 |
$40,865k |
|
|
NBIX 2 1/4 5/15/24 (64125CAD1)
|
30,770,000 |
$40,541k |
|
|
UNIQURE N.V. (N90064101)
|
517,700 |
$40,458k |
|
|
KINISKA PHARMACEUTIC (G5269C101)
|
2,799,577 |
$37,906k |
|
|
ZYMEWORKS INC (98985W102)
|
1,708,472 |
$37,586k |
|
|
AQUINOX PHARMACEUTICALS INC (03842B101)
|
10,934,154 |
$25,805k |
|
|
AXSOME THERAPEUTICS INC (05464T104)
|
772,286 |
$19,886k |
|
|
Xencor Inc. (98401F105)
|
428,120 |
$17,523k |
|
|
MERUS N V (N5749R100)
|
1,160,014 |
$16,994k |
|
|
BMRN 0.599 08/01/24 (09061GAH4)
|
15,000,000 |
$15,566k |
|
|
ACORDA THERAPEUTICS INC COM (00484M106)
|
2,011,189 |
$15,426k |
|
|
LA JOLLA PHARMACEUTICAL CO (503459604)
|
1,559,231 |
$14,423k |
|
|
AIMMUNE THERAPEUTICS INC (00900T107)
|
673,908 |
$14,031k |
|
|
IDERA PHARMACEUTICALS INC (45168K405)
|
4,605,822 |
$12,298k |
|
|
PROTAGONIST THERAPEUTICS INC (74366E102)
|
995,082 |
$12,050k |
|
|
MARKER THERAPEUTICS INC (57055L107)
|
1,500,000 |
$11,880k |
|
|
AEGLEA BIOTHERAPEUTICS INC (00773J103)
|
1,713,604 |
$11,738k |
|
|
Assembly Biosciences Inc (045396108)
|
803,246 |
$10,836k |
|
|
SANGAMO THERAPEUTICS (800677106)
|
999,823 |
$10,768k |
|
|
Catalyst Pharmaceuticals Inc (14888U101)
|
2,559,461 |
$9,828k |
|
|
Syros Pharmaceuticals Inc (87184Q107)
|
974,835 |
$9,027k |
|
|
ALKERMES PLC (G01767105)
|
400,000 |
$9,016k |
|
|
DERMIRA INC (24983L104)
|
906,943 |
$8,670k |
|
|
ALBIREO PHARMA INC (01345P106)
|
250,000 |
$8,060k |
|
|
APELLIS PHARMACEUTICALS INC (03753U106)
|
313,725 |
$7,950k |
|
|
MILESTONE PHARMACEUTICALS IN (59935V107)
|
266,667 |
$7,240k |
|
|
Anaptysbio Inc (032724106)
|
113,086 |
$6,380k |
|
|
ABEONA THERAPEUTICS INC (00289Y107)
|
1,288,235 |
$6,158k |
|
|
HOOKIPA PHARMA INC (43906K100)
|
892,857 |
$6,009k |
|
|
ORCHARD THERAPEUTICS PLC (68570P101)
|
405,702 |
$5,676k |
|
|
HALOZYME THERAPEUTICS INC (40637H109)
|
299,969 |
$5,153k |
|
|
Bluebird Bio Inc (09609G100)
|
40,000 |
$5,088k |
|
|
Bellicum Pharmaceuticals Inc (079481107)
|
2,677,818 |
$4,552k |
|
|
MENLO THERAPEUTICS (586858102)
|
700,000 |
$4,193k |
|
|
G1 THERAPEUTICS INC COM (3621LQ109)
|
127,236 |
$3,901k |
|
|
NGM BIOPHARMACEUTICALS INC (62921N105)
|
250,000 |
$3,660k |
|
|
VIKING THERAPEUTICS INC COM (92686J106)
|
425,000 |
$3,528k |
|
|
Acceleron Pharma Inc (00434H108)
|
83,900 |
$3,447k |
|
|
CRINETICS PHARMACE (22663K107)
|
132,985 |
$3,325k |
|
|
GALAPAGOS NV (36315X101)
|
25,072 |
$3,233k |
|
|
ACHILLION PHARMACEUTICALS (00448Q201)
|
1,095,359 |
$2,936k |
|
|
Aravive Inc (03890D108)
|
484,947 |
$2,910k |
|
|
Xbiotech Inc (98400H102)
|
380,442 |
$2,884k |
|
|
HARPOON THERAPEUTICS INC (41358P106)
|
214,285 |
$2,786k |
|
|
FORTY SEVEN INC (34983P104)
|
250,000 |
$2,650k |
|
|
AUTOLUS THERAPEUTICS PLC (05280R100)
|
156,773 |
$2,524k |
|
|
Y-MABS THERAPEUTICS INC (984241109)
|
102,800 |
$2,351k |
|
|
CYCLERION THERAPEUTI (23255M105)
|
202,581 |
$2,320k |
|
|
SPRING BK PHARMACEUTICALS IN (849431101)
|
613,144 |
$2,263k |
|
|
NEXTCURE INC (65343E108)
|
150,000 |
$2,247k |
|
|
CYTOMX THERAPEUTICS INC (23284F105)
|
194,377 |
$2,181k |
|
|
MOLECULAR TEMPLATES INC COM (608550109)
|
254,230 |
$2,123k |
|
|
Intellia Therapeutics Inc (45826J105)
|
128,538 |
$2,104k |
|
|
IDEAYA BIOSCIENCES INC (45166A102)
|
200,000 |
$1,992k |
|
|
CHEMOCENTRYX INC (16383L106)
|
207,029 |
$1,925k |
|
|
CONSTELLATION PHARMCETICLS I (210373106)
|
133,333 |
$1,637k |
|
|
GALMED PHARMACEUTICALS LTD (M47238106)
|
215,594 |
$1,585k |
|
|
AILERON THERAPEUTICS INC (00887A105)
|
2,040,000 |
$1,469k |
|
|
DOVA PHARMACEUTICALS INC (25985T102)
|
99,405 |
$1,402k |
|
|
FOAMIX PHARMACUTICLS (M46135105)
|
498,189 |
$1,186k |
|
|
SIERRA ONCOLOGY INC (82640U107)
|
2,000,000 |
$1,120k |
|
|
ADAMAS PHARMACEUTICALS INC (00548A106)
|
172,630 |
$1,070k |
|
|
INFINITY PHARMACEUTICALS INC (45665G303)
|
580,400 |
$1,045k |
|
|
ARCUS BIOSCIENCES INC COM (03969F109)
|
121,534 |
$966k |
|
|
FULGENT GENETICS INC (359664109)
|
125,000 |
$835k |
|
|
Affimed NV (N01045108)
|
200,000 |
$574k |
|
|
AQUESTIVE THERAPEUTICS INC (03843E104)
|
99,600 |
$418k |
|
|
SUNESIS PHARMACEUTICALS INC (867328700)
|
556,665 |
$405k |
|
|
Ritter Pharmaceuticals, Inc. (767836307)
|
279,999 |
$300k |
|
|
DYNAVAX TECHNOLOGIES CORP (268158201)
|
75,000 |
$299k |
|
|
Trillium Therapeutics Inc. (89620X506)
|
505,262 |
$166k |
|
De nombreuses personnes ont été brûlées par des fraudes et des stratagèmes de Ponzi. Nous avons donc créé ce site Web pour vous aider, en tant qu’investisseur potentiel, à obtenir les faits, à trouver le meilleur des moyens, et à éviter la fraude et les stratagèmes de Ponzi.
Toutes les informations fournies sur ce site sont fournies sans garantie et à des fins d'information uniquement.
InvestingReview.org ne fournit pas de conseils en investissement. InvestingReview.org n'est pas un conseiller en investissement et n'est ni endossé ni affilié à un organisme de réglementation américain ou non américain.
Entreprises récemment recherchées
Remarque: les données de recherche sont accumulées par des tiers et actualisées une fois par jour.